InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU – Get Rating)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $8.24. InfuSystem shares last traded at $7.37, with a volume of 99,645 shares.
InfuSystem Stock Performance
The company has a 50-day moving average price of $8.71. The firm has a market capitalization of $152.26 million, a price-to-earnings ratio of 737.74 and a beta of 1.20. The company has a quick ratio of 1.48, a current ratio of 1.86 and a debt-to-equity ratio of 0.72.
Institutional Trading of InfuSystem
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wasatch Advisors Inc. raised its stake in InfuSystem by 18.6% during the 1st quarter. Wasatch Advisors Inc. now owns 859,679 shares of the medical instruments supplier’s stock valued at $8,425,000 after acquiring an additional 135,076 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of InfuSystem by 8.6% during the 1st quarter. Vanguard Group Inc. now owns 859,052 shares of the medical instruments supplier’s stock worth $8,418,000 after buying an additional 68,242 shares in the last quarter. Meros Investment Management LP raised its stake in shares of InfuSystem by 51.2% during the 4th quarter. Meros Investment Management LP now owns 836,985 shares of the medical instruments supplier’s stock worth $7,265,000 after buying an additional 283,591 shares in the last quarter. Cove Street Capital LLC raised its stake in shares of InfuSystem by 37.4% during the 3rd quarter. Cove Street Capital LLC now owns 559,757 shares of the medical instruments supplier’s stock worth $3,913,000 after buying an additional 152,242 shares in the last quarter. Finally, Harbert Fund Advisors Inc. raised its stake in shares of InfuSystem by 51.9% during the 4th quarter. Harbert Fund Advisors Inc. now owns 557,721 shares of the medical instruments supplier’s stock worth $4,841,000 after buying an additional 190,594 shares in the last quarter. 53.78% of the stock is owned by hedge funds and other institutional investors.
InfuSystem Company Profile
InfuSystem Holdings, Inc engages in the provision of healthcare services. It operates through the Integrated Therapy Services and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on providing electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics.
- Get a free copy of the StockNews.com research report on InfuSystem (INFU)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.